PAM
SER icon

Panagora Asset Management’s Serina Therapeutics SER Stock Holding History

Panagora Asset Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,281
Closed -$146K – 2616
2019
Q4 		$146K Sell
2,281
-1,792
-44% -$96.8K ﹤0.01% 1711
2019
Q3 		$281K Buy
4,073
+1,879
+86% +$178K ﹤0.01% 1512
2019
Q2 		$283K Buy
2,194
+1,707
+351% +$231K ﹤0.01% 1660
2019
Q1 		$69K Buy
+487
New +$71.2K ﹤0.01% 1972

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Panagora Asset Management's SER Position: Q1 2020 in Review

Panagora Asset Management sold out of Serina Therapeutics (SER) in Q1 2020, closing a stake of 2,281 shares — an estimated $146K sold.

Panagora Asset Management first reported a position in SER in Q1 2019 and held it in 4 quarters. The position peaked at $283K in Q2 2019. 49 funds tracked by Wall St. Rank hold SER as of Q1 2020.

  • Panagora Asset Management reported no remaining Serina Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Panagora Asset Management sold 2,281 Serina Therapeutics shares in Q1 2020, an estimated $146K.
  • Panagora Asset Management first reported a position in Serina Therapeutics in Q1 2019 and held it in 4 quarters.
  • Panagora Asset Management's Serina Therapeutics position peaked at $283K in Q2 2019.
  • 49 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2020.

Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.